Impact of Obesity on Target Organ Damage in Patients with Metabolic Syndrome.

Svetlana KostićIvan TasićNikola StojanovićJelena RakocevicMarina Deljanin IlićDragan ĐorđevićViktor StoičkovIsidora Tasić

Published in: Diagnostics (Basel, Switzerland) (2024)

MetSy and obesity significantly alter the levels of NO metabolites, iNOS, ox-LDL-Chol, and PAI-1. High prevalence of NAFLD in obese patients with MetSy requires active screening and treatment of potential risk factors.

Keyphrases

metabolic syndrome
insulin resistance
weight loss
risk factors
uric acid
type diabetes
high fat diet induced
adipose tissue
cardiovascular risk factors
bariatric surgery
weight gain
ms ms
oxidative stress
risk assessment
body mass index
skeletal muscle
liver fibrosis